Latest filing published 01 Sept 2026 for NUTRA PHARMA CORP.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -61.0%Entry US$0.28 · Close at T+365 US$0.11
- -44.8%Entry US$0.42 · Close at T+365 US$0.23
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Rik J. Deitsch: trading record in brief
This profile gathers the share dealings of Rik J. Deitsch across 2 companies, led by Nutra Pharma Corp and Belarus Capital Corp. Over a trading history stretching from 13 March 2008 to 21 August 2026, the count stands at 18 filings.
Every open-market trade on record is a purchase: 11 purchases worth €197.3M, and no sale. The totals exclude 1 filing filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 6 share grants.
A typical purchase (the median) is worth €78k. For 5 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 80% of cases, with a median move of +84.3%. This is a record of the past, not a forecast.
Most recently, on 1 September 2026, the filings show a transaction in Nutra Pharma Corp. The last purchase on record was published on 26 June 2018, which is 3,057 days ago. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Rik J. Deitsch
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 12,000,000 shares0Series B Preferred StockSEC:0001493152-26-041002:0
- 1,250,000 shares@ US$0.08Nutra Pharma Corp Common StockSEC:0001387131-18-002844:0Canonical exit: 9 Jul 2014 (T+90)
- 506,900 shares@ US$0.24Nutra Pharma Corp Common StockSEC:0001387131-18-002844:1
- 4,000,000 shares@ US$0.185Nutra Pharma Corp Common StockSEC:0001387131-18-002844:2
- 4,000,000 shares@ US$0.0135Nutra Pharma Corp Common StockSEC:0001387131-18-002844:3
- 15,000,000 shares@ US$0.0067Nutra Pharma Corp Common StockSEC:0001387131-18-002844:4Canonical exit: 3 Oct 2016 (T+90)
- 15,000,000 shares@ US$0.005Nutra Pharma Corp Common StockSEC:0001387131-18-002844:5Canonical exit: 19 Mar 2017 (T+90)
- 7,500,000 shares@ US$0.022Nutra Pharma CorpSEC:0001144204-14-017004:0
- 200,000 shares@ US$0.0149Nutra Pharma CorpSEC:0001144204-14-017004:1Canonical exit: 10 Mar 2013 (T+90)
- 10,000,000 shares@ US$0.01Nutra Pharma CorpSEC:0001144204-14-017004:2Canonical exit: 19 Mar 2013 (T+90)
- 25,000,000 shares@ US$0.004Nutra Pharma CorpSEC:0001144204-14-017004:3Canonical exit: 25 Sept 2013 (T+90)
- 25,000,000 shares@ US$0.0025Nutra Pharma CorpSEC:0001144204-14-017004:4Canonical exit: 8 Dec 2013 (T+90)
- 11,760,000 shares@ US$0.014Nutra Pharma CorpSEC:0001144204-14-017004:5
- 148,000 shares@ US$1,741.88Common StockSEC:0001144204-12-024115:0Canonical exit: 22 Jul 2012 (T+90)
- 6,800,000 sharesCommon StockSEC:0001144204-12-022335:0
- 500,000 sharesCommon Stock, $.001 par valueSEC:0001144204-10-020134:0Canonical exit: 23 Jun 2010 (T+90)
- 5,000,000 shares@ US$0.025Common StockSEC:0001144204-08-019849:0Canonical exit: 11 Jun 2008 (T+90)
- 48,000,000 shares@ US$0.025Common StockSEC:0001144204-08-019849:1Canonical exit: 12 Jun 2008 (T+90)
18 of 18 declarations